Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chymotrypsin-like serine protease is a member of the serine protease superfamily characterized by a highly conserved active site serine and a preference for cleaving peptide bonds following large hydrophobic amino acids such as phenylalanine, tryptophan, and tyrosine[1][2][3]. The canonical example is chymotrypsin, a digestive enzyme secreted by the pancreas, but this group comprises a large family including enzymes involved in digestion, blood coagulation, immunity, and viral protein processing[2][3][6][7]. These proteases function by using the nucleophilic serine in the catalytic triad to facilitate peptide bond hydrolysis and are involved in various physiological and pathological processes, ranging from protein digestion in the gut to activation of viral polyproteins in viruses such as SARS-CoV-2[1][2][3][6][7]. Owing to their central roles, they are important therapeutic targets for enzyme inhibitors (including antiviral drugs and anti-inflammatory agents), and their dysregulation is implicated in disease processes such as cancer, inflammation, infection, and neurodegeneration[2][3][4][7].
Covalent active site inhibition (serine-modifying inhibitory drugs form covalent adducts) Competitive inhibition (small molecules block the substrate pocket) Irreversible inhibition (serpins, pharmaceuticals)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chymotrypsin-like serine protease.